LSD1 Antikörper (C-Term)
Kurzübersicht für LSD1 Antikörper (C-Term) (ABIN7449396)
Target
Alle LSD1 (KDM1A) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- Rabbit anti-BHC110/LSD1 Antibody, Affinity Purified
-
Homologie
- Mouse
-
Aufreinigung
- Affinity Purified
-
Immunogen
- between AA 825 and C-term
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IHC: 1:500 - 1:2,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
WB: 1:5,000 - 1:15,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- LSD1 (KDM1A) (Lysine (K)-Specific Demethylase 1A (KDM1A))
-
Andere Bezeichnung
- BHC110/LSD1
-
Hintergrund
- Background: BHC110/LSD1 is a histone demethylase and a component of several histone deacetylase complexes. BHC110/LSD1 is able to specifically catalyze the demethylation of Lys4 of histone H3. As part of histone deacetylase complexes BHC110/LSD1 functions as a corepressor of transcription. BHC110/LSD1 has also been demonstrated to interact with the androgen receptor and stimulate androgen-receptor-dependent transcription.
-
Gen-ID
- 23028
-
NCBI Accession
- NP_055828
-
UniProt
- O60341
-
Pathways
- Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Negative Regulation of intrinsic apoptotic Signaling, Warburg Effekt
Target
-